Avilamycin

Star0

DB11375ExperimentalVet approvedSmall molecule

Avilamycin: Overview.

Formula / weight: C₆₁H₈₈Cl₂O₃₂ · 1404.24 g/mol (avg)
Code names: LY 048 740

Resolves to

Compound

UNII720WDX56D3CAS11051-71-1

Clinical / RWD

RxNorm1661561

Structure

InChIKeyXIRGHRXBGGPPKY-OTPQUNEMSA-NSMILES

[H][C@]12COC(O[C@@H]3O[C@H](COC)[C@@H](O[C@@H]4O[C@H](C)[C@H](OC)[C@H](O[C@H]5C[C@@]6(C)OC7(C[C@@H](O)[C@H](O[C@H]8C[C@@H](O)[C@H](OC(=O)C9=C(C)C(Cl)=C(O)C(Cl)=C9OC)[C@@H](C)O8)[C@@H](C)O7)O[C@]6([H])[C@@H](C)O5)[C@H]4O)[C@H](O)[C@@H]3OC)[C@H](OC(=O)C(C)C)[C@]1([H])O[C@@]1(O2)O[C@H](C)[C@@](O)(C(C)=O)[C@]2([H])OCO[C@@]12[H]

What you can answer from here — as of March 06, 2025

56Drug interactionsStructured to mechanism, not free text

2Marketed productsAcross 1 country and 1 labeller

Which companies are running trials of Avilamycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account